Screener
Bausch + Lomb BLCO Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Bausch + Lomb in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Bausch + Lomb’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001860742-26-000088
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Payments of noncontrolling interest distributions | (7) | (9) |
| Net cash provided by financing activities | 14 | 121 |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | (1) | 31 |
| Net decrease in cash and cash equivalents and restricted cash | (19) | (44) |
| Cash and cash equivalents and restricted cash, beginning of period | 397 | 316 |
| Cash and cash equivalents and restricted cash, end of period | $378 | $272 |
| Non-cash Investing Activities | ||
| Accrued purchases of property, plant and equipment | $29 | $43 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Bausch + Lomb's cash & equivalents?
- Bausch + Lomb (BLCO) reported cash & equivalents of $378M in Q2 2026.
- How has Bausch + Lomb's cash & equivalents changed year-over-year?
- Bausch + Lomb's cash & equivalents increased by 39.0% year-over-year, from $272M to $378M.
- What is the long-term trend for Bausch + Lomb's cash & equivalents?
- Over 5 years (2020 to 2025), Bausch + Lomb's cash & equivalents has grown at a 10.8% compound annual growth rate (CAGR), from $238M to $397M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Bausch + Lomb's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude